Upadacitinib vs Zanidatamab

## Upadacitinib vs Zanidatamab: Overview

This comparison examines the pharmacological differences between **Upadacitinib** and **Zanidatamab**.

## Mechanism of Action

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Upadacitinib — 9-14 hours; Zanidatamab — N/A.

## Chemical Properties

**Molecular Formula**: Upadacitinib — C17H19F3N6O; Zanidatamab — N/A.

**Molecular Weight**: Upadacitinib — 380.3700 g/mol; Zanidatamab — N/A.

**Type**: Upadacitinib — Small molecule; Zanidatamab — Antibody.